The simultaneous overexpression of APOC2 and CD36 in THP-1 or MOLM-13 AML cell lines enhances cell proliferation, triggered by ERK and LYN phosphorylation (a downstream CD36 target), in comparison with APOC2 or CD36 overexpression alone. The gene discussed is APOC2; the disease is acute myeloid leukemia.